|
AKRO Akero Therapeutics Inc 1744659 |
| Balance Sheet |
|
Current Assets
|
770,380,000 |
|
Assets
|
825,886,000 |
|
Current Liabilities
|
39,754,000 |
|
Liabilities
|
75,774,000 |
|
Equity
|
750,112,000 |
|
Shares Out
|
69,431,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-230,107,000 |
|
Investing Cash Flow
|
-109,708,000 |
| Market Analysis |
Market Cap
|
1,863,868,704 |
|
Price
|
44.96 |
|
BVPS
|
10.80 |
|
PB
|
4.11 |
|
EPS
|
-3.41 |
|
PS
|
0.46 |
|
FCF
|
-339,815,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKRO documents filed with the SEC.
AKRO Filings
Clear
